CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

Seiya Saito, Hirohisa Okabe, Masayuki Watanabe, Takatsugu Ishimoto, Masaaki Iwatsuki, Yoshifumi Baba, Youhei Tanaka, Junji Kurashige, Yuji Miyamoto, Hideo Baba

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of the CD44 isoforms.CD44v6 has been reported to correlate with tumor progression and poor prognosis in colorectal cancer. However, the relevance of CD44s and CD44v6 to epithelial-mesenchymal transition (EMT) remains unclear. Immunohistochemistry was performed to investigate the clinical importance of CD44s and CD44v6 and their relevance to EMT in 113 patients with stage II/III colorectal cancer treated by curative resection. The relevance of CD44v6 knockdown to the phenotype of colon cancer cells was examined using small interfering RNA (siRNA) specific for CD44v6 in vitro. CD44v6 expression showed a significant inverse correlation with E-cadherin expression (P=0.0007) and a positive correlation with vimentin expression (P=0.0096). A multivariate analysis showed that high CD44v6 expression was an independent poor prognostic factor for disease-free survival (P=0.01, HR=3.05) and overall survival (P=0.025, HR=3.16). The clinical significance and the relevance of CD44s expression to EMT markers was noted to a lesser extent compared to CD44v6 expression. The knockdown of CD44v6 decreased vimentin expression, cell invasion and HGF-induced cell migration, but conferred only a slight effect on E-cadherin expression in colon cancer cells (HCT116 and LoVo). CD44v6 is related to poor outcome of patients with colorectal cancer via upregulation of the mesenchymal phenotype.

Original languageEnglish
Pages (from-to)1570-1578
Number of pages9
JournalOncology reports
Volume29
Issue number4
DOIs
Publication statusPublished - Apr 2013

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Saito, S., Okabe, H., Watanabe, M., Ishimoto, T., Iwatsuki, M., Baba, Y., Tanaka, Y., Kurashige, J., Miyamoto, Y., & Baba, H. (2013). CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncology reports, 29(4), 1570-1578. https://doi.org/10.3892/or.2013.2273